tm
Seeing Is Believing
tm
Seeing Is Believing
LYRA is currently covered by 2 analysts
Lyra Therapeutics 's activity chart (see below) currently has 12 price targets and 23 ratings on display. The stock rating distribution of LYRA is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 65.33 days.
Highest price target for LYRA is $20, Lowest price target is $7.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.
Currently out of the existing stock ratings of LYRA, 4 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-May-2024
$16
$14.68 (1112.12%)
$16
1 years 1 months 8 days ago
(14-Aug-2025)
0/6 (0%)
$8.9 (125.35%)
Hold Since 06-May-2024
1 years 3 months 20 days ago
(02-Jun-2025)
0/1 (0%)
$568 (312.09%)
Buy Since 24-May-2022
2 years 1 months 7 days ago
(15-Aug-2024)
0/1 (0%)
$450 (150.00%)
Sell Since 07-May-2024
2 years 4 months 15 days ago
(07-May-2024)
0/3 (0%)
$242 (78.57%)
Hold Since 07-May-2024
$25
$23.68 (1793.94%)
2 years 4 months 15 days ago
(07-May-2024)
1/1 (100%)
$4 (19.05%)
392
What is LYRA (Lyra Therapeutics ) average time for price targets to be met?
Which analyst most recently updated their price target on LYRA (Lyra Therapeutics )?
Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?
Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?
Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?
